Antonia Stammberger

4PUBLICATIONS
49CO-AUTHORS
Tissue engineeringPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 21, 2026
Preclinical evaluation of homodimeric FAPI target modules for UniCAR-mediated targeting of FAP-expressing tumor and stromal cells.

|Nov 06, 2025
Intratumoral regulatory T cells are associated with treatment response to neoadjuvant chemotherapy and prognosis in gastroesophageal adenocarcinoma.

Franziska Baenke, Antonia Stammberger, Ulrich Sommer

|Feb 09, 2025
RevCAR-mediated T-cell response against PD-L1-expressing cells turns suppression into activation.

Eugenia Crespo, Liliana R Loureiro, Antonia Stammberger

|Oct 02, 2024
TIMP1 Mediates Astrocyte-Dependent Local Immunosuppression in Brain Metastasis Acting on Infiltrating CD8+ T Cells.

Neibla Priego, Ana de Pablos-Aragoneses, María Perea-García

Pageof 1

Frequent Collaborators

3 joint publications

Marc Schmitz

2 joint publications

Luise Rupp

1 joint publications

Neibla Priego

1 joint publications

Ana de Pablos-Aragoneses